Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Deep phenotyping reveals CRH and FKBP51-dependent behavioral profiles following chronic social stress exposure in male mice
    Published on 2024-10-22
    2 years ago
  • NPP Editorial: tides of progress
    Published on 2024-10-22
    2 years ago
  • Phytocannabinoids restore seizure-induced alterations in emotional behaviour in male rats
    Published on 2024-10-21
    2 years ago
  • Efficacy and safety of JNJ-42165279, a fatty acid amide hydrolase inhibitor, in adolescents and adults with autism spectrum disorder: a randomized, phase 2, placebo-controlled study
    Published on 2024-10-16
    2 years ago
  • PET clinical study of novel antipsychotic LB-102 demonstrates unexpectedly prolonged dopamine receptor target engagement
    Published on 2024-10-16
    2 years ago
  • Small-molecule natural product sophoricoside reduces peripheral neuropathic pain via directly blocking of NaV1.6 in dorsal root ganglion nociceptive neurons
    Published on 2024-10-16
    2 years ago
  • Sex-specific and developmental effects of early life adversity on stress reactivity are rescued by postnatal knockdown of 5-HT1A autoreceptors
    Published on 2024-10-12
    2 years ago
« Previous 1 … 78 79 80 81 82 … 143 Next »
Journal of Psychopharmacology
  • Commentary on Cochrane review: “Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder”
    Published on 2022-10-11
    4 years ago
  • Pharmaco-fUS in cognitive impairment: Lessons from a preclinical model
    Published on 2022-10-07
    4 years ago
  • Associations between MDMA/ecstasy use and physical health in a U.S. population-based survey sample
    Published on 2022-10-03
    4 years ago
  • The low risk for early renal damage during lithium treatment has not changed over time
    Published on 2022-09-19
    4 years ago
  • Individual differences in cocaine-induced conditioned place preference in male rats: Behavioral and transcriptomic evidence
    Published on 2022-09-19
    4 years ago
  • The association between N-methyl-d-aspartate receptor availability and glutamate levels: A multi-modal PET-MR brain imaging study in first-episode psychosis and healthy controls
    Published on 2022-09-19
    4 years ago
  • Deepening our understanding of psychedelics by expanding psychedelic data collection in the United States National Survey on Drug Use and Health
    Published on 2022-09-16
    4 years ago
« Previous 1 … 78 79 80 81 82 … 154 Next »
European Neuropsychopharmacology
  • Grey matter morphology in women with premenstrual dysphoric disorder treated with a selective progesterone receptor modulator
    Published on 2022-11-05
    4 years ago
  • Excess resource use and costs of physical comorbidities in individuals with mental health disorders: A systematic literature review and meta-analysis
    Published on 2022-11-05
    4 years ago
  • Antidepressant discontinuation syndrome: A state-of-the-art clinical review
    Published on 2022-11-05
    4 years ago
  • Psychiatric vulnerability in animal models
    Published on 2022-11-05
    4 years ago
  • Gender Dysphoria and its associated hurdles in Pakistan
    Published on 2022-11-05
    4 years ago
  • Current approaches to precision medicine in psychiatry: Are we just spinning our wheels?
    Published on 2022-11-04
    4 years ago
  • Together is better: Let’s overcome the heterogeneity problem
    Published on 2022-11-04
    4 years ago
« Previous 1 … 78 79 80 81 82 … 170 Next »

   Pharma Pub